Fluorescence Imaging of Adalimumab-680LT in Inflammatory Bowel Disease
NCT06117423
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Crohn Disease
Ulcerative Colitis
Interventions
DRUG:
Adalimumab-680LT
OTHER:
Control
Sponsor
University Medical Center Groningen